Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 24, Number 12—December 2018

Capnocytophaga canimorsus Capsular Serovar and Disease Severity, Helsinki Hospital District, Finland, 2000–2017

Estelle Hess1, Francesco Renzi1, Panu Karhunen1, Mélanie Dol, Adrien Lefèvre, Jenni Antikainen, Elodie Carlier, Johanna Hästbacka2, and Guy R. Cornelis2Comments to Author 
Author affiliations: University of Namur, Namur, Belgium (E. Hess, F. Renzi, M. Dol, A. Lefèvre, E. Carlier, G.R. Cornelis); University of Eastern Finland, Kuopio, Finland (P. Karhunen); University of Helsinki and Helsinki University Hospital, Helsinki, Finland (J. Antikainen, J. Hästbacka)

Main Article

Table 2

Patient demographics, clinical characteristics, and contact with dogs, Helsinki Hospital District, Finland, 2000–2017*

Characteristic No. patients† Value
Age, y, median (IQR)
55 (48.3–64.8)
Sex 73
M 38 (52.1)

35 (47.9)
Immune compromised 73 7 (9.6)
Smoking 48 30 (62.5)
Alcohol abuse
18 (36.7)
Contact with dog 73
Not known 21 (28.8)
Contact but not bitten 15 (20.5)

37 (50.7)
Disease severity 70
Regular ward or emergency department 45 (64.3)
High surveillance unit 11 (15.7)
Intensive care unit

14 (20.0)
Length of hospital stay, d, median (IQR) 62 6 (3–13.3)
Deaths at day 30 73 3 (4.1)
Deaths at 1 y 61 4 (6.6)
Amputation 73 6 (8.2)

*Values are no. (%) patients except as indicated. IQR, interquartile range.
†Because of missing data, number of patients in each category varied.

Main Article

1These first authors contributed equally to this article.

2These authors were co–principal investigators.

Page created: November 19, 2018
Page updated: November 19, 2018
Page reviewed: November 19, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.